Compare ADMA Biologics Inc (ADMA) vs Freshworks Inc (FRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Freshworks Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Freshworks Inc trades at $11.86 (market cap $3.31B). The key difference: Freshworks Inc is the larger of the two by market cap, and Freshworks Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | FRSH | |
|---|---|---|
Market Cap | $2.22B | $3.31B |
Sector | Health | Technology |
52-Week High | $20.38 | $13.97 |
52-Week Low | $7.60 | $6.88 |
Enterprise Value | $2.29B | $2.68B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →
